Akenroye AT, McEwan C, Saini SS. Montelukast reduces symptom severity and frequency in patients with angioedema-predominant chronic spontaneous urticaria. J Allergy Clin Immunol Pract 2018;6(4):1403-5. https://www.ncbi.nlm.nih.gov/pubmed/29733981
Australasian society of clinical immunology and allergy (ASCIA) HAE working party, Katelaris C, Smith W, Baumgart K, Gillis D, Jordan A, et al. ASCIA hereditary angioedema (HAE) position paper and management plan. ASCIA; 2022.
Horiuchi T, Hide M, Yamashita K, Ohsawa I. The use of tranexamic acid for on-demand and prophylactic treatment of hereditary angioedema-A systematic review. Journal of Cutaneous Immunology and Allergy 2018;1(4):126-38. https://onlinelibrary.wiley.com/doi/abs/10.1002/cia2.12029
van den Elzen M, Go M, Knulst AC, Blankestijn MA, van Os-Medendorp H, Otten HG. Efficacy of Treatment of Non-hereditary Angioedema. Clin Rev Allergy Immunol 2018;54(3):412-31. https://www.ncbi.nlm.nih.gov/pubmed/27672078
